Glycobond
The company’s first product is an assay for HCC diagnosis, HepaCheC®
Sweden
1 employees
Grant
Total: $50.00K
Biotechnology, Health Care
General Information
Sweden
BounceWatch is an independent company data service, not affiliated with Glycobond. To contact Glycobond, visit glycobond.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Glycobond compare?
A PDF of Glycobond and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Glycobond soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
Sweden Market
Biotechnology
About Glycobond
Business keywords: medical diagnostics, cancer diagnosis, liver diseases, carbohydrate-binding peptides, recombinant technology, CE-marked assay, HCC diagnosis, liver cancer monitoring
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Grant | €50.00K | 1 |
EASME - EU Executive Agency for SMEs
|
01 Dec 2017 |
| Venture Round | Undisclosed | 1 |
|
11 Apr 2017 |
| Venture Round | Undisclosed | 1 |
|
08 Apr 2015 |
Glycobond Alternatives & Competitors
View All Alternatives
Delcath Systems, Inc. is an interventional oncology company focused on the treatment of metastatic l...
Developing cancer diagnostic panels based on epigenetic bio markers
Delivering next-generation liquid biopsy platform for the earliest detection and most accurate cance...
FAQ About Glycobond
Source: BounceWatch company record for Glycobond, https://bouncewatch.com/company/glycobond, updated 10 October 2024. When citing, please name BounceWatch and link this page.
